Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism / Q000494:pharmacology*; D001665:Binding Sites; D001921:Brain / Q000201:enzymology; D002118:Calcium / Q000502:physiology; D002352:Carrier Proteins / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007700:Kinetics; D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; D051381:Rats; D011954:Receptors, Dopamine / Q000502:physiology
D000067956:Adenylyl Cyclase Inhibitors; D014150:Antipsychotic Agents; D002352:Carrier Proteins; D007527:Isoenzymes; D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; D011954:Receptors, Dopamine; D002118:Calcium